SAN FRANCISCO, April 25, 2018 -- Hagens Berman Sobol Shapiro LLP reminds investors in Henry Schein, Inc. (NASDAQ:HSIC) of the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York. If you purchased or otherwise acquired Henry Schein securities between March 7, 2013 and February 12, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/HSIC
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On February 12, 2018, the United States Federal Trade Commission (“FTC”) announced it sued Henry Schein and two other dental supply companies.
The FTC charges the Company: (a) illegally restrained price competition for dental products in the United States; (b) distorted prices and undermined the ability of independent dentists to obtain lower prices and discounts for dental products; (c) deprived independent dentists of the benefits of vigorous price and service competition among full-service, national dental distributors; (d) unreasonably reduced output of dental products to dental buying groups; and (e) eliminated or reduced the competitive bidding process for sales to these buying groups.
This news drove the price of Henry Schein shares down $4.79, or about 6.6%, to close at $67.39 on February 13, 2018.
“Henry Schein investors have suffered enormous losses,” said Hagens Berman partner Reed Kathrein. “We’re focused on Defendants’ statements to investors about the Company’s revenues and purported industry competition.”
Whistleblowers: Persons with non-public information regarding Henry Schein should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


How Marco Pharma International Preserves German Homeopathic Traditions in America
Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Disney Issues Cease-and-Desist to ByteDance Over Alleged AI Copyright Infringement
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents 



